Engineering BHK-21 cells by dual knockout of host-restriction factors Cav1 and HDAC6 achieved a marked increase in FMDV titers for scalable vaccine production

ABSTRACT Foot-and-mouth disease virus (FMDV) vaccine production depends on BHK-21 cells, but the high antigen dose required for biannual mass vaccination campaigns using an inactivated vaccine limits global vaccine supply. In this study, a targeted small-molecule screen identified baicalein (caveolin-1 inhibitor) and tubacin (HDAC6 inhibitor) as potent enhancers of FMDV replication in BHK-21 cells. Cav1 was shown to act as an early restriction factor: its inhibition increased the viral entry and consequently produced a sixfold higher virus yield. Cav1 inhibition also primed p53-dependent intrinsic apoptosis, raising p53 phosphorylation and BAX/BIM transcripts, shifting cells into early apoptosis, and promoting cytolytic spread. HDAC6 was shown to function as a post-entry restriction factor: its inhibition elevated α-tubulin acetylation, enhancing viral RNA and protein expression and producing four to six times titer boost. Finally, using CRISPR/Cas9, we generated Cav1/HDAC6 double-knockout (dKO) BHK-21 cells , targeting two host restriction factors that impose entry and post-entry barriers to FMDV replication. The engineered BHK-21 cells in both adherent and suspension culture formats produced 10- to 20-fold higher virus titers across field FMDV serotype “O” and FMDV vaccine strains of serotypes “O,” “A,” and “Asia 1.” Reintroducing either factor restored restriction, confirming their roles as host restriction factors. These findings reveal a dual-layer host defense mechanism and establish an engineered, high-yield BHK-21 cell line for enhanced viral production and improved vaccine manufacturing efficiency. IMPORTANCE Foot-and-mouth disease (FMD) imposes substantial economic losses on livestock-producing countries through reduced animal productivity and trade restrictions. Control relies on biannual herd vaccination, generating a demand for vaccine that often exceeds current manufacturing capacity. FMD vaccine antigen is conventionally produced in BHK-21 cells; however, limited viral yields increase production costs and constrain supply. Here, we identify caveolin-1 and HDAC6 as host restriction factors for foot-and-mouth disease virus (FMDV) in BHK-21 cells. Caveolin-1 restricts FMDV at the entry stage, whereas HDAC6 acts at a post-entry step. Knockout of these factors enhances viral yields by 10- to 20-fold across FMDV serotypes O, A, and Asia 1—the three serotypes included in India’s trivalent vaccine program. These findings indicate that BHK-21 cells deficient in caveolin-1 and HDAC6 could substantially improve FMDV propagation and provide a scalable, cost-effective platform for vaccine manufacturing.

Authors

Institutions

Publication Details

Journal
Journal of Virology
Published
2026-11-16
DOI
https://doi.org/10.1128/jvi.01164-26
Primary Topic
Animal Disease Management and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Engineering BHK-21 cells by dual knockout of host-restriction factors Cav1 and HDAC6 achieved a marked increase in FMDV titers for scalable vaccine production

Supriya Bhattacharya, Nitin Khandelwal, Alka Nokhwal, Sreenivasulu Kilari et al.
1 links
Journal of Virology
Animal Disease Management and Epidemiology
article

Engineering BHK-21 cells by dual knockout of host-restriction factors Cav1 and HDAC6 achieved a marked increase in FMDV titers for scalable vaccine production

Supriya Bhattacharya, Nitin Khandelwal, Alka Nokhwal, Sreenivasulu Kilari, Naveen Kumar, Yogesh Chander, Himanshu Kamboj, Assim Verma, Garvit Kumar, Riyesh T
article en

Abstract

ABSTRACT Foot-and-mouth disease virus (FMDV) vaccine production depends on BHK-21 cells, but the high antigen dose required for biannual mass vaccination campaigns using an inactivated vaccine limits global vaccine supply. In this study, a targeted small-molecule screen identified baicalein (caveolin-1 inhibitor) and tubacin (HDAC6 inhibitor) as potent enhancers of FMDV replication in BHK-21 cells. Cav1 was shown to act as an early restriction factor: its inhibition increased the viral entry and consequently produced a sixfold higher virus yield. Cav1 inhibition also primed p53-dependent intrinsic apoptosis, raising p53 phosphorylation and BAX/BIM transcripts, shifting cells into early apoptosis, and promoting cytolytic spread. HDAC6 was shown to function as a post-entry restriction factor: its inhibition elevated α-tubulin acetylation, enhancing viral RNA and protein expression and producing four to six times titer boost. Finally, using CRISPR/Cas9, we generated Cav1/HDAC6 double-knockout (dKO) BHK-21 cells , targeting two host restriction factors that impose entry and post-entry barriers to FMDV replication. The engineered BHK-21 cells in both adherent and suspension culture formats produced 10- to 20-fold higher virus titers across field FMDV serotype “O” and FMDV vaccine strains of serotypes “O,” “A,” and “Asia 1.” Reintroducing either factor restored restriction, confirming their roles as host restriction factors. These findings reveal a dual-layer host defense mechanism and establish an engineered, high-yield BHK-21 cell line for enhanced viral production and improved vaccine manufacturing efficiency. IMPORTANCE Foot-and-mouth disease (FMD) imposes substantial economic losses on livestock-producing countries through reduced animal productivity and trade restrictions. Control relies on biannual herd vaccination, generating a demand for vaccine that often exceeds current manufacturing capacity. FMD vaccine antigen is conventionally produced in BHK-21 cells; however, limited viral yields increase production costs and constrain supply. Here, we identify caveolin-1 and HDAC6 as host restriction factors for foot-and-mouth disease virus (FMDV) in BHK-21 cells. Caveolin-1 restricts FMDV at the entry stage, whereas HDAC6 acts at a post-entry step. Knockout of these factors enhances viral yields by 10- to 20-fold across FMDV serotypes O, A, and Asia 1—the three serotypes included in India’s trivalent vaccine program. These findings indicate that BHK-21 cells deficient in caveolin-1 and HDAC6 could substantially improve FMDV propagation and provide a scalable, cost-effective platform for vaccine manufacturing.

Journal of Virology
National Research Centre on Equines (IN), ICMR-National Institute of Virology (IN)
Department of Biotechnology, Ministry of Science and Technology, India
Good health and well-being
Animal Disease Management and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon